Literature DB >> 16479516

Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.

Judith E Mueller1, Seydou Yaro, Yves Traore, Lassana Sangare, Zekiba Tarnagda, Berthe-Marie Njanpop-Lafourcade, Raymond Borrow, Bradford D Gessner.   

Abstract

OBJECTIVES: We sought to describe Neisseria meningitidis immunity and its association with pharyngeal carriage in Burkina Faso, where N. meningitidis serogroup W-135 and serogroup A disease are hyperendemic and most of the population received polysaccharide A/C vaccine during 2002.
METHODS: We collected oropharyngeal swab samples from healthy residents of Bobo-Dioulasso (4-14 years old, n=238; 15-29 years old, n=250) monthly during February-June 2003; N. meningitidis isolates were analyzed using polymerase chain reaction and serogrouped using immune sera. Serum samples were collected at the first and last clinic visit and analyzed for anti-A, anti-C, anti-W-135, and anti-Y immunoglobulin G (IgG) concentrations and anti-A and anti-W-135 bactericidal titers.
RESULTS: N. meningitidis was carried at least once by 18% of participants; this carriage included strains from serogroups W-135 (5%) and Y and X (both <1%) but not from serogroups A, B, or C. At baseline, the prevalence of putatively protective specific IgG concentrations (> or =2 microg/mL) and bactericidal titers (> or =8) was 85% and 54%, respectively, against serogroup A, and 6% and 22%, respectively, against serogroup W-135. Putatively protective anti-W-135 IgG concentrations and bactericidal titers were of short duration and were not associated with carriage.
CONCLUSION: N. meningitidis serogroup W-135 strains did not induce immunity, despite their circulation. Carriage of serogroup A strains was rare despite the hyperendemic incidence of serogroup A meningitis during 2003 in Bobo-Dioulasso. A vaccine that includes serogroup W-135 antigen and eliminates serogroup A carriage is needed for sub-Saharan Africa.

Entities:  

Mesh:

Year:  2006        PMID: 16479516     DOI: 10.1086/500511

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.

Authors:  Paul A Kristiansen; Fabien Diomandé; Stanley C Wei; Rasmata Ouédraogo; Lassana Sangaré; Idrissa Sanou; Denis Kandolo; Pascal Kaboré; Thomas A Clark; Abdoul-Salam Ouédraogo; Ki Ba Absatou; Charles D Ouédraogo; Musa Hassan-King; Jennifer Dolan Thomas; Cynthia Hatcher; Mamoudou Djingarey; Nancy Messonnier; Marie-Pierre Préziosi; Marc LaForce; Dominique A Caugant
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

2.  Immunogenicity of meningococcal polysaccharide ACWY vaccine in primary immunized or revaccinated adults.

Authors:  C Ferlito; R Biselli; M S Cattaruzza; R Teloni; S Mariotti; E Tomao; G Salerno; M S Peragallo; P Lulli; S Caporuscio; A Autore; G Bizzarro; V Germano; M I Biondo; A Picchianti Diamanti; S Salemi; R Nisini; R D'Amelio
Journal:  Clin Exp Immunol       Date:  2018-09-20       Impact factor: 4.330

3.  Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009.

Authors:  Caroline L Trotter; Helen Findlow; Ray Borrow
Journal:  Clin Vaccine Immunol       Date:  2011-12-21

4.  Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7.

Authors:  Gunnstein Norheim; Abraham Aseffa; Mohammed Ahmed Yassin; Getahun Mengistu; Afework Kassu; Dereje Fikremariam; Wegene Tamire; Yared Merid; E Arne Høiby; Dominique A Caugant; Elisabeth Fritzsønn; Torill Tangen; Tsegaye Alebel; Degu Berhanu; Morten Harboe; Einar Rosenqvist
Journal:  Clin Vaccine Immunol       Date:  2007-02-14

5.  Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity.

Authors:  Judith E Mueller; Seydou Yaro; Berthe-Marie Njanpop-Lafourcade; Aly Drabo; Régina S Idohou; Sita S Kroman; Oumarou Sanou; Serge Diagbouga; Yves Traoré; Lassana Sangaré; Raymond Borrow; Bradford D Gessner
Journal:  J Infect Dis       Date:  2011-10-12       Impact factor: 5.226

6.  Seasonality of meningitis in Africa and climate forcing: aerosols stand out.

Authors:  L Agier; A Deroubaix; N Martiny; P Yaka; A Djibo; H Broutin
Journal:  J R Soc Interface       Date:  2012-12-05       Impact factor: 4.118

7.  Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa.

Authors:  P T Beernink; D A Caugant; J A Welsch; O Koeberling; D M Granoff
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

8.  Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003.

Authors:  Judith E Mueller; Lassana Sangaré; Berthe-Marie Njanpop-Lafourcade; Zekiba Tarnagda; Yves Traoré; Seydou Yaro; Raymond Borrow; Bradford D Gessner; Pierre Nicolas
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

9.  Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008.

Authors:  Caroline L Trotter; Seydou Yaro; Berthe-Marie Njanpop-Lafourcade; Aly Drabo; Sita S Kroman; Regina S Idohou; Oumarou Sanou; Leah Bowen; Helen Findlow; Serge Diagbouga; Bradford D Gessner; Ray Borrow; Judith E Mueller
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

10.  A multi-state spatio-temporal Markov model for categorized incidence of meningitis in sub-Saharan Africa.

Authors:  L Agier; M Stanton; G Soga; P J Diggle
Journal:  Epidemiol Infect       Date:  2012-09-21       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.